Episode Details

South Africa’s weight-loss drug revolution is heating up as generics of Ozempic and Wegovy hit the market, sparking a price war and forcing insurers to rethink coverage. Once diabetes treatments, these GLP-1 drugs now dominate for weight loss, with demand soaring and clinics multiplying. Regulators are tightening controls against unsafe knock-offs, while patients face steep costs and limited insurance access—unless prices drop fast, these life-changing meds may stay out of reach for most.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/1286c92a81b63cde